HIV and OUD Service and Funding Matrices Guide and Template
Resource updated 04/18/2024
Resource updated 04/18/2024
Resource updated 03/11/2024
Resource updated 06/18/2024
Resource updated 09/19/2023
Resource updated 10/04/2023
Resource updated 05/10/2023
Resource updated 03/18/2024
Resource updated 03/04/2024
Description of how a modified Directly Observed Therapy (mDOT) program increased uptake of DOPT and the priority populations that experienced the uptake.
Resource (Conference Presentation) updated 09/14/2023
The objective of this study is to assess key stakeholders, including patients, for readiness to adopt a new standard of care. Because many people with HIV in Alabama experience low literacy, low income, and are racial minorities, data suggests they will experience greater barriers to healthcare information technology, like PROs and Telehealth.
Resource (Conference Presentation) updated 09/14/2023
Using a multidisciplinary approach to harness the electronic patient portal for completion of RWHAP six-month recertification documents, we were able to create a more patient-centered method that complies with program requirements. We will discuss the challenges, opportunities, and results of using such technology in program recertification.
Resource (Conference Presentation) updated 09/14/2023
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
Project to determine the feasibility of integrating primary care services into syringe exchange programs.
Resource (Conference Presentation) updated 09/14/2023
Strategies, findings, and lessons learned from the RWHAP SPNS initiative that aims to strengthen systems of care between the RWHAP and entities funded in response to the opioid epidemic.
Resource (Conference Presentation) updated 09/14/2023
Listening Session on how Policy Clarification Notice 16-02 and how the HRSA HAB RWHAP service categories and allowable uses of funds can be refreshed to best reflect new and emerging needs, science, and service delivery models.
Resource (Conference Presentation) updated 09/14/2023
Overview of RWHAP SPNS E2i Initiative implementation materials.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 10/23/2023
Resource updated 07/10/2024
Doub elijibilite Medicare-Medicaid la kapab yon sijè konplèks ki gen anpil niyans. Zouti sa a se pou ede moun ki enfekte ak VIH konprann fondman elijibilite ak pwoteksyon asirans lan, avantaj inik ki genyen lè moun doubman elijib pou toulede pwogram yo, ansanm ak kijan Pwogram Ryan White VIH/SIDA (RWHAP) a kapab sipòte kliyan ki doubman elijib yo.
Zouti sa a abòde:
Resource updated 01/10/2024
La doble elegibilidad para Medicare-Medicaid puede ser un asunto complejo con muchas particularidades. Este recurso fue preparado con la intención de ayudar a las personas con VIH a entender los aspectos básicos relativos a la elegibilidad y la cobertura, los beneficios particulares de ser doblemente elegible para ambos programas, y cómo el Programa Ryan White contra el VIH/SIDA (RWHAP, por sus siglas en inglés) puede apoyar a los usuarios con doble elegibilidad.
Este recurso cubre los siguientes aspectos:
Resource updated 01/10/2024